Magdalena Bieniasz

Oklahoma Medical Research Foundation

$2,456,587

Attributed

$2,456,587

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $594.8K · FY2017–24

$1M$750K$500K$250K$0

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$2,456,587 · 4

By mechanism

P20$1,532,103 · 2

K22$479,115 · 1

R21$445,369 · 1

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Cancer Cell”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,576,599
Bronwen Shaw · Medical College Of Wisconsin$19,560,999
Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$16,493,829
Leonard Freedman · Leidos Biomedical Research, Inc.$15,694,188

Research focus

Cancer CellCancer PatientMalignant NeoplasmsOvarian NeoplasmChemotherapyKnock-DownTumorMediatingMalignant Neoplasm Of OvaryCancer Cell LinePathway InteractionsPatient Derived Xenograft ModelPrecision MedicineCancer TherapyPaclitaxelResponseMortalityCisplatinNovel Therapeutic InterventionCellsChemoresistanceCell ProliferationInnovationOklahoma